Accent Therapeutics is a biopharmaceutical company.
Accent Therapeutics has raised $75.0M in total funding. The most recent round was Series C. The last funding was announced in January 2024.
Accent Therapeutics's investors include AbbVie, Bristol-Myers Squibb, EcoR1 Capital, Atlas Venture, Google Ventures.
Accent Therapeutics is headquartered in Lexington, United States.
Accent Therapeutics is a biopharmaceutical company.
Accent Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Accent Therapeutics — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/accent-therapeutics. Accessed July 19, 2026.
VCBacked. (2024). Accent Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/accent-therapeutics
{{cite web |title=Accent Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/accent-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated